Protective Effects of Ziziphus jujuba Mill. Leaves Against Metabolic Dysfunction-Associated Steatotic Liver Disease Are Associated with Gut Microbiota and Hepatic Metabolic Remodeling

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent chronic liver disorder with limited effective pharmacological treatments. Ziziphus jujuba Mill. leaves (ZJL) contain multiple bioactive compounds, but their effects on MASLD and underlying mechanisms remain unclear. Methods: The chemical constituents of ethanolic ZJL extract were characterized using UHPLC-Q-Orbitrap MS. A high-fat diet (HFD)-induced MASLD mouse model was used to evaluate its protective effects. Serum biochemical parameters, liver histopathology, and inflammatory indicators were assessed. Gut microbiota and hepatic metabolic alterations were investigated using 16S rDNA sequencing and untargeted metabolomics, respectively. Potential microbiota–metabolite associations and key regulatory targets were further explored by correlation analysis, molecular docking, and qRT-PCR. Results: Fifty-five compounds were identified in ZJL, mainly flavonoids, organic acids, and triterpenoids. ZJL treatment significantly reduced HFD-induced body weight gain, dyslipidemia, hyperglycemia, hepatic injury, inflammation, and lipid accumulation. ZJL also partially restored gut microbial homeostasis, particularly by decreasing the abundances of Blautia and Dorea. Metabolomic analysis indicated that glycerophospholipid metabolism was the major affected pathway, together with fatty acid biosynthesis and cytochrome P450-related metabolism. Microbial alterations were closely associated with lipid-related metabolites. Moreover, ZJL downregulated key genes, including Pla2g2a, Fasn, and Cyp2e1. Conclusions: ZJL alleviated HFD-induced MASLD, accompanied by coordinated alterations in gut microbiota composition, hepatic metabolism, and lipid-related gene expression, suggesting that these changes may contribute to its protective effects.

Authors

Institutions

Publication Details

Journal
Nutrients
Published
2026-11-12
DOI
https://doi.org/10.3390/nu18223760
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Protective Effects of Ziziphus jujuba Mill. Leaves Against Metabolic Dysfunction-Associated Steatotic Liver Disease Are Associated with Gut Microbiota and Hepatic Metabolic Remodeling

Tianshuo Zhang, Dongsheng Jia, Jie Liu, Ding Xiaotang et al.
Nutrients
Liver Disease Diagnosis and Treatment
article

Protective Effects of Ziziphus jujuba Mill. Leaves Against Metabolic Dysfunction-Associated Steatotic Liver Disease Are Associated with Gut Microbiota and Hepatic Metabolic Remodeling

Tianshuo Zhang, Dongsheng Jia, Jie Liu, Ding Xiaotang, Huiyi Zhang, Dingfeng Zhao, 顧家恬, Man Wang, Guangzhao Zhou
article en

Abstract

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent chronic liver disorder with limited effective pharmacological treatments. Ziziphus jujuba Mill. leaves (ZJL) contain multiple bioactive compounds, but their effects on MASLD and underlying mechanisms remain unclear. Methods: The chemical constituents of ethanolic ZJL extract were characterized using UHPLC-Q-Orbitrap MS. A high-fat diet (HFD)-induced MASLD mouse model was used to evaluate its protective effects. Serum biochemical parameters, liver histopathology, and inflammatory indicators were assessed. Gut microbiota and hepatic metabolic alterations were investigated using 16S rDNA sequencing and untargeted metabolomics, respectively. Potential microbiota–metabolite associations and key regulatory targets were further explored by correlation analysis, molecular docking, and qRT-PCR. Results: Fifty-five compounds were identified in ZJL, mainly flavonoids, organic acids, and triterpenoids. ZJL treatment significantly reduced HFD-induced body weight gain, dyslipidemia, hyperglycemia, hepatic injury, inflammation, and lipid accumulation. ZJL also partially restored gut microbial homeostasis, particularly by decreasing the abundances of Blautia and Dorea. Metabolomic analysis indicated that glycerophospholipid metabolism was the major affected pathway, together with fatty acid biosynthesis and cytochrome P450-related metabolism. Microbial alterations were closely associated with lipid-related metabolites. Moreover, ZJL downregulated key genes, including Pla2g2a, Fasn, and Cyp2e1. Conclusions: ZJL alleviated HFD-induced MASLD, accompanied by coordinated alterations in gut microbiota composition, hepatic metabolism, and lipid-related gene expression, suggesting that these changes may contribute to its protective effects.

NutrientsVol. 18(22)
Hebei Medical University (CN), Hebei Academy of Agriculture and Forestry Sciences (CN)
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon